SAN DIEGO--(BUSINESS WIRE)--CRISPR QC, a pioneering biotechnology company in San Diego, is excited to announce the launch of several groundbreaking products designed to revolutionize the field of gene ...
CRISPR Therapeutics (NASDAQ:CRSP) gains visibility as biotechnology activity aligns with broader movements across the Nasdaq ...
For some diseases, gene therapies offer the potential for lifelong disease amelioration and even cure. And these immensely important novel biotechnologies may be on the cusp of a boom. That is in part ...
When Victoria Gray was still a baby, she started howling so inconsolably during a bath that she was rushed to the emergency room. The diagnosis was sickle-cell disease, a genetic condition that causes ...
CRISPR Therapeutics has upcoming catalysts and a strong cash position, making it a solid investment opportunity. The company's pipeline includes therapies for diabetes, immuno-oncology, and ...
With the first medical therapy approved and systems like CRISPR-Cas showing up in complex cells, there’s a lot happening in the genome editing field. By Amber Dance/Knowable Magazine Published Jan 26, ...
CRISPR Therapeutics (CRSP 2.23%) received great news last week. Its gene-editing therapy, which it has been developing with Vertex Pharmaceuticals, obtained approval from the Food and Drug ...
6don MSN
Teens may have come up with a new way to detect, treat Lyme disease using CRISPR gene editing
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
Hosted on MSN
Web-based tool improves CRISPR accuracy by identifying off-target effects across genetic variations
Genome editing technologies like CRISPR-Cas9 have transformed biology, medicine, and agriculture, but concerns remain about unintended edits at off-target DNA sites. These off-target effects can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback